Showing results (241-250 of 304) with videos related to
Sort By:
Pageof 31
Journal of Neurology|December 24, 2025
CSF biomarkers of neuroinflammation are associated with regional atrophySerap Özlü, Martin Dyrba, Alice Grazia, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 12, 2024
Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive declineStefan J Teipel, Martin Dyrba, Luca Kleineidam, et al.Journal of Alzheimer'S Disease : JAD|March 11, 2022
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's DiseaseSteffen Wolfsgruber, Luca Kleineidam, Anne-Sophie Weyrauch, et al.Journal of Alzheimer'S Disease : JAD|October 10, 2019
Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic UsefulnessStefan J Teipel, Jan O Kuper-Smith, Claudia Bartels, et al.Alzheimer'S Research & Therapy|August 2, 2019
Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE studyLisa Miebach, Steffen Wolfsgruber, Alexandra Polcher, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression riskLuisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, et al.Immunity|February 4, 2025
NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer's disease progressionRóisín M McManus, Max P Komes, Angelika Griep, et al.Science Translational Medicine|July 4, 2014
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosisGernot Kleinberger, Yoshinori Yamanishi, Marc Suárez-Calvet, et al.Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated StatesFrancisco Hernandez-Rasco, Rocío Ruiz, Itziar de Rojas, et al.CNS Drugs|December 21, 2017
Targeting Neuroinflammation to Treat Alzheimer's DiseaseA Ardura-Fabregat, E W G M Boddeke, A Boza-Serrano, et al.Pageof 31